Critics argue that NIH directors should have term limits. Others say leadership continuity matters. Who's right?

In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.

Agencies will have to show a “direct causal link” to “manifest bodily harm,” not just an increased risk of disease.

The administration had cut crucial funding for mRNA-based therapies. The rest of the world might step in and benefit.

As the risk of measles mounts, health care workers face an unusual challenge: Many don't know what it looks like.

The MAHA movement’s embrace of unorthodox therapies has deep roots in U.S. history, says law professor Lewis Grossman.

Corruption in science? Academic discrimination? Research censorship? Government cover-ups? Undark wants to hear about it. Email us at tips@undark.org or visit our contact page for more secure options.

It’s possible that traditional discipline could have prevented the shooting. Henderson had a history of violence and threats against family, students, and teachers. The teenager had recently been ...

Emanating from smokestacks, vehicle engines, construction projects, and fires large and small, airborne pollution – sometimes smaller than the width of a human hair, and very often the product of ...

A skin condition tied to delusions is posing a riddle for doctors: What to do when a diagnosis causes offense?

HHS states it was cleaning up "dated content." But advocates for people with autism say the warnings are still needed.

For decades, a global transition has been underway: The slow, sometimes clumsy shift from fossil fuels to renewable energy. Changing just one industry requires a significant infrastructural makeover.